The groups were told to refile their lawsuits on Tuesday, as the judge said did not give a required 24-hour notice to the San Francisco attorney's office.
Later this year, Merck expects to refile Arcoxia in the U.S. and either spin off or do an initial public offering for its pharmacy-benefits manager unit, Medco.